Journal article Open Access

DrugProt corpus genes and proteins annotation guidelines [GPRO - Biocreative 5.2]

Rabal, Obdulia; Krallinger, Martin


Dublin Core Export

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Rabal, Obdulia</dc:creator>
  <dc:creator>Krallinger, Martin</dc:creator>
  <dc:date>2021-06-15</dc:date>
  <dc:description>Annotation guidelines used for the annotations of gene and protein-related objects of the CHEMDNER, ChemProt and DrugProt corpora.

 

Introduction

The annotation guidelines have been refined after iterative cycles of annotations of sample documents. It also incorporated suggestions made by curators as well as observations of annotation inconsistencies encountered when comparing results from different human curators.

In brief, the annotated GPROs include genes, gene products
(proteins, RNA), DNA/protein sequence elements and protein families, domains and complexes. The aim of the iterative manual annotation cycles was to improve the quality and consistency of the guidelines, in order to make them more intuitive and easier to follow.

 

Please, cite:

@article{perez2016markyt, title={The Markyt visualisation, prediction and benchmark platform for chemical and gene entity recognition at BioCreative/CHEMDNER challenge}, author={P{\'e}rez-P{\'e}rez, Martin and P{\'e}rez-Rodr{\'\i}guez, Gael and Rabal, Obdulia and Vazquez, Miguel and Oyarzabal, Julen and Fdez-Riverola, Florentino and Valencia, Alfonso and Krallinger, Martin and Louren{\c{c}}o, An{\'a}lia}, journal={Database}, volume={2016}, year={2016}, publisher={Oxford Academic}}

 

Related Resources:


	Web
	DrugProt corpus
	Evaluation library
	Relations annotation guidelines
	Chemicals and drugs annotation guidelines
	DrugProt FAQ
</dc:description>
  <dc:identifier>https://zenodo.org/record/4957577</dc:identifier>
  <dc:identifier>10.5281/zenodo.4957577</dc:identifier>
  <dc:identifier>oai:zenodo.org:4957577</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>doi:10.5281/zenodo.4957576</dc:relation>
  <dc:relation>url:https://zenodo.org/communities/medicalnlp</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>https://creativecommons.org/licenses/by/4.0/legalcode</dc:rights>
  <dc:subject>NLP</dc:subject>
  <dc:subject>biomedical NLP</dc:subject>
  <dc:subject>biocreative</dc:subject>
  <dc:subject>NER</dc:subject>
  <dc:title>DrugProt corpus genes and proteins annotation guidelines [GPRO - Biocreative 5.2]</dc:title>
  <dc:type>info:eu-repo/semantics/article</dc:type>
  <dc:type>publication-article</dc:type>
</oai_dc:dc>
240
194
views
downloads
All versions This version
Views 240240
Downloads 194194
Data volume 53.3 MB53.3 MB
Unique views 215215
Unique downloads 179179

Share

Cite as